| Highly functionalized biaryls via Suzuki–Miyaura cross‐coupling catalyzed by Pd@ MOF under batch and continuous flow regimes V Pascanu, PR Hansen, A Bermejo Gómez, C Ayats, AE Platero‐Prats, ... ChemSusChem 8 (1), 123-130, 2015 | 113 | 2015 |
| Explanation for main features of structure–genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2 I Shamovsky, L Ripa, L Borjesson, C Mee, B Nordén, P Hansen, ... Journal of the American Chemical Society 133 (40), 16168-16185, 2011 | 76 | 2011 |
| Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA I Shamovsky, L Ripa, N Blomberg, LA Eriksson, P Hansen, C Mee, ... Chemical Research in Toxicology 25 (10), 2236-2252, 2012 | 35 | 2012 |
| Denmark and European integration P Hansen Cooperation and Conflict 4 (1), 13-46, 1969 | 28 | 1969 |
| Thalidomide inhibits early atherogenesis in apoE-deficient mice. M Chew, J Zhou, A Daugherty, T Eriksson, S Ellermann-Eriksen, ... APMIS. Supplementum, 113-116, 2003 | 21 | 2003 |
| The structure of the debate in the Danish EC campaign: A study of an opinion-policy relationship P Hansen, M Small, K Siune J. Common Mkt. Stud. 15, 93, 1976 | 20 | 1976 |
| Identification and optimization of pyrrolidine derivatives as highly potent ghrelin receptor full agonists M Cooper, A Llinas, P Hansen, M Caffrey, A Ray, S Sjödin, I Shamovsky, ... Journal of Medicinal Chemistry 63 (17), 9705-9730, 2020 | 16 | 2020 |
| Hydroxyalkyl compounds T Eriksson, P Hansen, M Hemmerling, K Henriksson, T Klingstedt, ... US Patent 6,943,188, 2005 | 16 | 2005 |
| Compounds P Hansen, L Pettersson US Patent 6,951,874, 2005 | 14 | 2005 |
| Compounds P Hansen, L Pettersson US Patent 6,927,222, 2005 | 14 | 2005 |
| 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial P Hansen, K Lawitz, M Lepistö, H Lönn, A Ray US Patent 7,998,984, 2011 | 12 | 2011 |
| Glucocorticosteroids, processes for their preparation, pharmaceutical compositions containing them and their use in therapy H Bladh, F Burkamp, B Gabos, P Hansen, S Ivanova, K Lawitz US Patent 8,163,724, 2012 | 11* | 2012 |
| Novel compounds P Hansen, L Pettersson US Patent App. 10/204,754, 2003 | 11 | 2003 |
| Novel compounds P Hansen, L Pettersson US Patent App. 10/204,789, 2003 | 11 | 2003 |
| 2-pyridone derivatives as neutrophil elastase inhibitors and their use P Hansen, H Lönn, A Nikitidis US Patent 8,063,073, 2011 | 10 | 2011 |
| Novel combinations F Burkamp, P Hansen US Patent App. 12/749,888, 2010 | 9 | 2010 |
| 2-pyridone derivatives as netrophil elastase inhibitors and their use 2 P Hansen, K Lawitz, H Loenn, A Nikitidis | 9 | 2006 |
| 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial P Hansen, M Ivarsson, K Lawitz, H Lönn, A Nikitidis, A Ray US Patent 8,114,881, 2012 | 8 | 2012 |
| Novel compounds F Burkamp, P Hansen US Patent App. 12/749,919, 2010 | 7 | 2010 |
| 2-pyridine derivatives as inhibitors of neutrophile elastase P Hansen, K Lawitz, L Hans, A Nikitidis | 7 | 2006 |
